Deals Rumor Mill: Harvard Drug, Canaan, Alibaba

By Chelsea Naso (July 31, 2014, 5:05 PM EDT) -- New York-based Court Square Capital Partners could rake in $1 billion by putting generic drug-focused pharmaceutical distributor Harvard Drug Group LLC on the auction block, sources told The Wall Street Journal on Thursday. Harvard Drug has tapped Credit Suisse Group to handle the sale process, which will likely draw the interest of other private equity firms and large pharmaceutical companies as more and more U.S. patients turn to generic drugs for cost savings, the report said....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!